Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Surgical treatment of hepatic metastases from gastric cancer

Surgical treatment of hepatic metastases from gastric cancer The purpose of the study was to investigate the clinical factors influencing the prognosis of patients submitted to hepatectomy for metastases from gastric cancer and their clinical role. We conducted a retrospective multicentre review. We evaluated how survival from surgery was influenced by patient-related, tumour-related and treatment-related prognostic factors. We analysed data on 144 patients submitted to hepatectomy for metastases from gastric cancer, in the synchronous and metachronous setting. In 117 cases, an R0 resection was achieved, while in 27 an R + hepatic resection was performed. Chemotherapy was administered to 55 patients. Surgical mortality was 2.1% and morbidity 21.5%. One-, 3-, and 5-year OS rates after surgery were 49.9, 19.4 and 11.6%, respectively, with a median OS of 12.0 months. T4 gastric cancer, H3 hepatic involvement, non-curative resection, recurrence after surgery, and abstention from chemotherapy were associated with a worse prognosis. Factor T and H displayed a clear (p < 0.001) cumulative effect. Our data show that R0 resection must be pursued whenever possible. The treatment of T4 gastric cancer with hepatic bilateral and diffuse metastasis (H3) should be considered carefully or it should be probably avoided. Finally, a multimodal treatment associating surgery and chemotherapy offers the best survival results. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Updates in Surgery Springer Journals

Surgical treatment of hepatic metastases from gastric cancer

Download PDF
6 pages

Loading next page...
 
/lp/springer_journal/surgical-treatment-of-hepatic-metastases-from-gastric-cancer-AMT0DKkn0S
Publisher
Springer Journals
Copyright
Copyright © 2018 by Italian Society of Surgery (SIC)
Subject
Medicine & Public Health; Surgery
ISSN
2038-131X
eISSN
2038-3312
DOI
10.1007/s13304-018-0536-2
pmid
29845462
Publisher site
See Article on Publisher Site

Abstract

The purpose of the study was to investigate the clinical factors influencing the prognosis of patients submitted to hepatectomy for metastases from gastric cancer and their clinical role. We conducted a retrospective multicentre review. We evaluated how survival from surgery was influenced by patient-related, tumour-related and treatment-related prognostic factors. We analysed data on 144 patients submitted to hepatectomy for metastases from gastric cancer, in the synchronous and metachronous setting. In 117 cases, an R0 resection was achieved, while in 27 an R + hepatic resection was performed. Chemotherapy was administered to 55 patients. Surgical mortality was 2.1% and morbidity 21.5%. One-, 3-, and 5-year OS rates after surgery were 49.9, 19.4 and 11.6%, respectively, with a median OS of 12.0 months. T4 gastric cancer, H3 hepatic involvement, non-curative resection, recurrence after surgery, and abstention from chemotherapy were associated with a worse prognosis. Factor T and H displayed a clear (p < 0.001) cumulative effect. Our data show that R0 resection must be pursued whenever possible. The treatment of T4 gastric cancer with hepatic bilateral and diffuse metastasis (H3) should be considered carefully or it should be probably avoided. Finally, a multimodal treatment associating surgery and chemotherapy offers the best survival results.

Journal

Updates in Surgery – Springer Journals

Published: May 29, 2018

References

  • Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model
    Adam, R; Chiche, L; Aloia, T
  • Liver resection for noncolorectal, non-neuroendocrine liver metastases—is hepatic resection justified as part of the oncosurgical treatment?
    Lehner, F; Ramackers, W; Bektas, H
  • Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors
    Ochiai, T; Sasako, M; Mizuno, S
  • Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer
    Ueda, K; Iwahashi, M; Nakamori, M
  • Hepatic resection for metastatic tumors from gastric cancer
    Okano, K; Maeba, T; Ishimura, K
  • Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer
    Hwang, S-E; Yang, D-H; Kim, C-Y
  • Indication for hepatic resection in the treatment of liver metastasis from gastric cancer
    Makino, H; Kunisaki, C; Izumisawa, Y
  • Benefits and limits of hepatic resection for gastric metastases
    Ambiru, S; Miyazaki, M; Ito, H
  • Hepatic resection of liver metastases from gastric carcinoma
    Miyazaki, M; Itoh, H; Nakagawa, K
  • Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection
    Shirabe, K; Shimada, M; Matsumata, T
  • Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer
    Sakamoto, Y; Sano, T; Shimada, K
  • Liver resection for metastatic gastric cancer
    Thelen, A; Jonas, S; Benckert, C
  • Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer
    Tsujimoto, H; Ichikura, T; Ono, S
  • Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?
    Garancini, M; Uggeri, F; Degrate, L
  • Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis
    Schildberg, CW; Croner, R; Merkel, S
  • Significance of surgical treatment of liver metastases from gastric cancer
    Miki, Y; Fujitani, K; Hirao, M
  • Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections
    Takemura, N; Saiura, A; Koga, R
  • Predictive factors improving survival after gastric and hepatic surgical treatment in gastric cancer patients with synchronous liver metastases
    Liu, J; Li, JH; Zhai, RJ
  • Metachronous hepatic metastases from gastric carcinoma: a multicentric survey
    Tiberio, GAM; Coniglio, A; Marchet, A
  • Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection?
    Tiberio, GAM; Baiocchi, GL; Morgagni, P
  • Japanese classification of gastric carcinoma: 3rd English edition
  • Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study
    Marrelli, D; Stefano, A; Manzoni, G
  • Influence of surgical resection of hepatic metastases from gastric adenocarcinoma on long-term survival: systematic review and pooled analysis
    Markar, SR; Mikhail, S; Malietzis, G
  • Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
    Cheon, SH; Rha, SY; Jeung, H-C
  • Kyushu Study Group of Clinical Cancer (2015) Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)
    Oki, E; Tokunaga, S; Emi, Y
  • Chirurgie des metastases hepatiques de cancers non colorectaux non endocrine. Monographies de l’association Franc¸aise de Chirurgie
    Chiche, L; Ducreux, M; Lebreton, G
  • Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond
    Choi, AH; Kim, J; Chao, J
  • Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors
    Koga, R; Junji, Y; Shigekazu, O